Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

S. 641119th Congress

A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada.

Read the full bill

Progress

  1. Introduced
  2. In committee Not yet
  3. Passed one chamber Not yet
  4. Passed Congress Not yet
  5. Sent to President Not yet
  6. Became law Not yet

In plain language

Safe and Affordable Drugs from Canada Act of 2025

This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.

Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.

An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs.

The FDA must publish a list of approved Canadian pharmacies on its website.

Summary by the Congressional Research Service, a nonpartisan office of the Library of Congress. Version summarized: Introduced in Senate.

Legislative history

  1. Senate

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  2. Introduced in Senate